Alvotech (ALVOW)

Profile

Full Name

Alvotech

Ticker Symbol

ALVOW

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Luxembourg

IPO

June 16, 2022

Indexes

Not included

Website

http://www.alvotech.com

Employees

1012

Key Details

Price

$1.30

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$489.68M(+435.56% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.30
ALVOW price is $1.30

30-Day Relative Volume

0.60
ALVOW 30-day relative volume is 0.60

Price Performance

Price Most recent change

-
ALVOW price change on Apr 11, 2025 is unknown

Price YTD change

-58.2%
ALVOW price is down -58.2% since January 1st

Price 1-year change

-
ALVOW price 1-year change is unknown

Price 3-year change

-
ALVOW price 3-year change is unknown

Price Range

Price All-time high

$6.31
ALVOW price is currently -79.40% below its historical high of $6.31

Price 3-year low

$0.50
ALVOW price is currently +161.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
ALVOW market capitalization value is unknown

Market cap 3-year change

-
ALVOW market capitalization 3-year change is unknown

Market cap All-time high

-
ALVOW market capitalization all-time high is unknown

Market cap sector rank

-
ALVOW market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
ALVOW shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
ALVOW shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.03
ALVOW beta is 2.03

200-day SMA

$2.49
ALVOW price is currently -47.73% below its 200-day simple moving average

50-day SMA

$2.08
ALVOW price is currently -37.43% below its 50-day simple moving average

RSI

41.41
ALVOW 14-day relative strength index is 41.41

Volume

0.60
ALVOW 30-day relative volume is 0.60

ATR

$0.31
ALVOW average true range is $0.31

10-day Historical Volatility

314.08%
ALVOW 10-day historical volatility is 314.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$489.68M
ALVOW annual revenue is $489.68 million

Revenue Analysts estimate

$642.64M
ALVOW annual revenue is currently -23.80% lower than the consensus analysts' forecast

Revenue 1-year change

+435.56%
ALVOW annual revenue is up +435.56% year-on-year

Revenue Sector rank

74.19%
ALVOW annual revenue is higher than 74.19% of companies in Healthcare sector

EPS

EPS

-
ALVOW annual earnings per share value is unknown

EPS Analysts estimate

-
ALVOW annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
ALVOW annual earnings per share 1-year change is unknown

EPS Sector rank

-
ALVOW annual earnings per share is unknown

Profit

Gross profit

$304.37M
ALVOW annual gross profit is $304.37 million

Gross margin

62.16%
ALVOW annual gross profit margin is 62.16%

Operating profit

$69.64M
ALVOW annual operating income is $69.64 million

Operating margin

14.22%
ALVOW annual operating profit margin is 14.22%

Net income

-$231.86M
ALVOW annual net profit is -$231.86 million

Net margin

-
ALVOW annual net profit margin value is unknown

Expenses

Total expenses

$420.04M
ALVOW annual total expenses is $420.04 million

Operating expenses

$234.73M
ALVOW annual total operating expenses is $234.73 million

Cost of goods sold

$185.31M
ALVOW annual cost of goods sold is $185.31 million

Selling, general & administrative expenses

$61.45M
ALVOW annual SGA is $61.45 million

Depreciation and amortization

$31.30M
ALVOW annual depreciation & amortization is $31.30 million

Interest expense

$153.99M
ALVOW annual interest expense is $153.99 million

Income tax

$14.30M
ALVOW annual income tax is $14.30 million

EBIT & EBITDA

EBIT

-$63.58M
ALVOW annual earnings before interest & taxes is -$63.58 million

EBITDA

$101.95M
ALVOW annual EBITDA is $101.95 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.22B
ALVOW annual total assets is $1.22 billion

Non current assets

$766.38M
ALVOW annual long term assets is $766.38 million

Current assets

$455.02M
ALVOW annual total current assets is $455.02 million

Cash and cash equivalents

$51.43M
ALVOW annual cash & cash equivalents is $51.43 million

Accounts receivable

$160.22M
ALVOW annual accounts receivable is $160.22 million

Inventory

$127.89M
ALVOW annual inventory is $127.89 million

Liabilities

Total liabilities

$1.63B
ALVOW annual total liabilities is $1.63 billion

Long term liabilities

$1.44B
ALVOW annual total long term liabilities is $1.44 billion

Current liabilities

$193.40M
ALVOW annual total current liabilities is $193.40 million

Accounts payable

$67.13M
ALVOW annual accounts payable is $67.13 million

Debt

Total debt

$1.19B
ALVOW annual total debt is $1.19 billion

Total debt 1-year change

+10.67%
ALVOW annual total debt is up +10.67% year-on-year

Long term debt

$1.15B
ALVOW annual long term debt is $1.15 billion

Short term debt

$32.70M
ALVOW annual short term debt is $32.70 million

Equity & Capital

Shareholders equity

-$412.77M
ALVOW annual stockholders equity is -$412.77 million

Book value

-$444.72M
ALVOW annual book value is -$444.72 million

Retained earnings

-$2.44B
ALVOW annual retained earnings is -$2.44 billion

Working capital

$261.62M
ALVOW annual working capital is $261.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$236.84M
ALVOW annual cash flow from operations is -$236.84 million

Cash from operations 1-year change

+24.13%
ALVOW annual cash flow from operations is up +24.13% year-on-year

Cash from investing

-$18.87M
ALVOW annual cash flow from investing activities is -$18.87 million

Cash from investing 1-year change

+59.28%
ALVOW annual cash flow from investing activities is up +59.28% year-on-year

Cash from financing

$297.31M
ALVOW annual cash flow from financing activities is $297.31 million

Cash from financing 1-year change

-1.33%
ALVOW annual cash flow from financing activities is down -1.33% year-on-year

CAPEX

CAPEX

$57.00M
ALVOW annual capital expenditures is $57.00 million

CAPEX 1-year change

+22.65%
ALVOW annual capital expenditures is up +22.65% year-on-year

Free Cash Flow

Free cash flow

-$293.84M
ALVOW annual free cash flow is -$293.84 million

Free cash flow 1-year change

+18.07%
ALVOW annual free cash flow is up +18.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

62.16%
ALVOW annual gross profit margin is 62.16%

Operating margin

14.22%
ALVOW annual operating profit margin is 14.22%

Net margin

-
ALVOW annual net profit margin value is unknown

ROA & ROE

ROA

-18.98%
ALVOW annual return on assets is -18.98%

ROE

56.17%
ALVOW annual return on equity is 56.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALVOW price to earnings ratio value is unknown

PE ratio Sector rank

-
ALVOW price to earnings ratio is unknown

PB Ratio

PB ratio

-
ALVOW price to book ratio value is unknown

PB ratio Sector rank

-
ALVOW price to book ratio is unknown

PS Ratio

PS ratio

-
ALVOW price to sales ratio value is unknown

PS ratio Sector rank

-
ALVOW price to sales ratio is unknown

Enterprise value

Enterprise value

-
ALVOW enterprise value value is unknown

Enterprise value Sector rank

-
ALVOW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
ALVOW EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
ALVOW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.35
ALVOW annual current ratio is 2.35

Quick ratio

1.69
ALVOW annual quick ratio is 1.69

Leverage

Debt to equity

-2.88
ALVOW annual debt to equity ratio is -2.88

Interest coverage ratio

-0.41
ALVOW annual interest coverage ratio is -0.41

Risk & Stability

Piotroski F-Score

-
ALVOW piotroski f-score value is unknown

Altman Z-Score

-
ALVOW altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jul 1, 22 Deutsche Bank
Hold

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Alvotech?
  • Does Alvotech pay dividends?
  • What sector is Alvotech in?
  • What industry is Alvotech in?
  • What country is Alvotech based in?
  • When did Alvotech go public?
  • Is Alvotech in the S&P 500?
  • Is Alvotech in the NASDAQ 100?
  • Is Alvotech in the Dow Jones?
  • When does Alvotech report earnings?

What is the ticker symbol for Alvotech?

The ticker symbol for Alvotech is NASDAQ:ALVOW

Does Alvotech pay dividends?

No, Alvotech does not pay dividends

What sector is Alvotech in?

Alvotech is in the Healthcare sector

What industry is Alvotech in?

Alvotech is in the Drug Manufacturers - Specialty & Generic industry

What country is Alvotech based in?

Alvotech is headquartered in Luxembourg

When did Alvotech go public?

Alvotech's initial public offering (IPO) was on June 16, 2022

Is Alvotech in the S&P 500?

No, Alvotech is not included in the S&P 500 index

Is Alvotech in the NASDAQ 100?

No, Alvotech is not included in the NASDAQ 100 index

Is Alvotech in the Dow Jones?

No, Alvotech is not included in the Dow Jones index

When does Alvotech report earnings?

The date for Alvotech's next earnings report has not been announced yet
On this page